Forte Biosciences is a biopharmaceutical company that is developing through preclinical trials its product candidate, FB-102, which is a proprietary therapeutic molecule with potentially autoimmune applications in such indications as graft-versus-host disease, vitiligo and alopecia areata. We show 1 historical shares outstanding datapoints in our FBRX shares outstanding history coverage, used to compute FBRX market cap on those dates.
Understanding the changing numbers of shares outstanding, the changing
share price, and the resulting changing FBRX market cap history over the course of time is important for investors
interested in comparing FBRX's market cap history versus its peers.
Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at
a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies,
and then calculating their respective market caps. Comparing the share price of FBRX versus a peer is one thing; comparing
FBRX market cap versus a peer is a completely different story.
Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares),
the market cap for a company like FBRX can fluctuate over the course of history.
With this page we aim to empower investors researching FBRX by allowing them to research the FBRX market cap history. |
Free FBRX Email Alerts:
Video: The Importance of Market Cap
